INTERNATIONAL PATENT: JIANGSU RE-STEM BIOTECHNOLOGY CO., LTD., THE JOHNS HOPKINS UNIVERSITY, CLEGG, RICHARD IAN FILES APPLICATION FOR "TREATMENT AND PREVENTION OF ALPHA-SYNUCLEIN-MEDIATED DISEASE"

GENEVA, Nov. 17 -- JIANGSU RE-STEM BIOTECHNOLOGY CO., LTD. (1463 Wuzhong Avenue, Bldg AlWuzhong DistrictSuzhou, Jiangsu 215104), THE JOHNS HOPKINS UNIVERSITY (3400 N. Charles StreetBaltimore, Maryland 21218), CLEGG, Richard Ian (Mewburn Ellis LLPAurora BuildingCounterslipBristol Gloucestershire BS1 6BX) filed a patent application (PCT/EP2025/062632) for "TREATMENT AND PREVENTION OF ALPHA-SYNUCLEIN-MEDIATED DISEASE" on May 08, 2025. With publication no. WO/2025/233460, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Ro...